Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.

Sofuoglu, Mehmet

Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report. [electronic resource] - Psychopharmacology Dec 2012 - 413-20 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

1432-2072

10.1007/s00213-012-2763-4 doi


Behavior, Addictive--physiopathology
Blood Pressure--drug effects
Cholinesterase Inhibitors--therapeutic use
Cognition--drug effects
Connecticut
Cross-Over Studies
Double-Blind Method
Female
Galantamine--therapeutic use
Heart Rate--drug effects
Humans
Infusions, Intravenous
Logistic Models
Male
Neuropsychological Tests
Nicotine--administration & dosage
Nicotinic Agonists--administration & dosage
Pilot Projects
Severity of Illness Index
Smoking--physiopathology
Smoking Cessation--methods
Smoking Prevention
Substance Withdrawal Syndrome--physiopathology
Surveys and Questionnaires
Task Performance and Analysis
Time Factors
Tobacco Use Disorder--drug therapy